• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care
Prostate Cancer : Episode 1

Episode 1 - CRPC: Recent Advances and Paradigm Shifts in Treatment

Video

During the opening segment of this panel discussion about recent advances and pharmacoeconomic considerations in the clinical management of Castration-Resistant Prostate Cancer (CRPC), discussion moderator Raoul S. Concepcion, MD, is joined by expert panelists David Crawford, MD, Jeffrey D. Dunn, PharmD, MBA, Michael Kolodziej, MD, and David Quinn, MD.

After the panelists briefly introduce themselves and explain their relationships to medical oncology, Dr Concepcion cites important statistics about the economic and clinical burden of CRPC.

Dr Quinn reviews the treatment landscape for CRPC and explains how a paradigm shift in the US Food and Drug Administration’s approval of agents to treat CRPC has improved the disease’s outlook.


Related Videos
Dr Vivek Subbiah
Lindsey Valenzuela, PharmD, APh, BCACP – screenshot by AJMC
Dr Scott Soefje
Robert Andrews, chief executive officer, Health Transformation Alliance
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Dr Scott Soefje
Dr Mark Fendrick
Dr Vishnukamal Golla
Mark Riggle, PharmD
Dr Sophia Humphreys
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.